Anstee QM - Search Results

1

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.

Weston CJ, Shepherd EL, Claridge LC, Rantakari P, Curbishley SM, Tomlinson JW, Hubscher SG, Reynolds GM, Aalto K, Anstee QM, Jalkanen S, Salmi M, Smith DJ, Day CP, Adams DH. Weston CJ, et al. Among authors: anstee qm. J Clin Invest. 2015 Feb;125(2):501-20. doi: 10.1172/JCI73722. Epub 2014 Dec 22. J Clin Invest. 2015. PMID: 25562318 Free PMC article. Clinical Trial.

2

Genetics of alcoholic and nonalcoholic fatty liver disease.

Anstee QM, Daly AK, Day CP. Anstee QM, et al. Semin Liver Dis. 2011 May;31(2):128-46. doi: 10.1055/s-0031-1276643. Epub 2011 May 2. Semin Liver Dis. 2011. PMID: 21538280 Review.

3

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.

Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. Al-Serri A, et al. Among authors: anstee qm. J Hepatol. 2012 Feb;56(2):448-54. doi: 10.1016/j.jhep.2011.05.029. Epub 2011 Jul 12. J Hepatol. 2012. PMID: 21756849

4

How big a problem is non-alcoholic fatty liver disease?

Anstee QM, McPherson S, Day CP. Anstee QM, et al. BMJ. 2011 Jul 18;343:d3897. doi: 10.1136/bmj.d3897. BMJ. 2011. PMID: 21768191 No abstract available.

5

Genetic modifiers of non-alcoholic fatty liver disease progression.

Anstee QM, Daly AK, Day CP. Anstee QM, et al. Biochim Biophys Acta. 2011 Nov;1812(11):1557-66. doi: 10.1016/j.bbadis.2011.07.017. Epub 2011 Aug 5. Biochim Biophys Acta. 2011. PMID: 21840395 Free article. Review.

6

A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'?

Anstee QM, Day CP. Anstee QM, et al. J Hepatol. 2012 Apr;56(4):987-9. doi: 10.1016/j.jhep.2011.10.002. Epub 2011 Oct 18. J Hepatol. 2012. PMID: 22015962 Free article.

7

S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.

Anstee QM, Day CP. Anstee QM, et al. J Hepatol. 2012 Nov;57(5):1097-109. doi: 10.1016/j.jhep.2012.04.041. Epub 2012 May 30. J Hepatol. 2012. PMID: 22659519 Free article. Review.

8

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease.

Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Taylor R, Day CP, Trenell MI. Hallsworth K, et al. Among authors: anstee qm. J Hepatol. 2013 Apr;58(4):757-62. doi: 10.1016/j.jhep.2012.11.015. Epub 2012 Nov 22. J Hepatol. 2013. PMID: 23178979

9

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD. McPherson S, et al. Among authors: anstee qm. Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf. Eur J Gastroenterol Hepatol. 2013. PMID: 23325287

10

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Anstee QM, Targher G, Day CP. Anstee QM, et al. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23507799 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters